v3.26.1
Debt
3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Debt

Note 6. Debt

In accordance with applicable SEC staff guidance and interpretations, as a BDC, with certain exceptions, the Company is permitted to borrow amounts such that its asset coverage ratio is at least 150% after such borrowing (if certain requirements are met). As of March 31, 2026 and December 31, 2025, the Company’s asset coverage ratio based on aggregated borrowings outstanding was 174.6% and 175.9%, respectively.

The Company’s outstanding borrowings as of March 31, 2026 and December 31, 2025 were as follows:

 

 

 

As of March 31, 2026

 

 

As of December 31, 2025

 

 

 

 

Total Aggregate

 

 

 

Principal

 

 

 

 

 

 

 

Total Aggregate

 

 

 

Principal

 

 

 

 

 

 

 

 

Principal Amount

 

 

 

Amount

 

 

 

Carrying

 

 

 

Principal Amount

 

 

 

Amount

 

 

 

Carrying

 

 

 

 

Committed

 

 

 

Outstanding

 

 

 

Value (1)

 

 

 

Committed

 

 

 

Outstanding

 

 

 

Value (1)

 

2019-1 Debt

 

$

 

272,000

 

 

$

 

272,000

 

 

$

 

270,265

 

 

$

 

272,000

 

 

$

 

272,000

 

 

$

 

270,224

 

March 2026 Notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

300,000

 

 

 

 

300,000

 

 

 

 

299,786

 

October 2026 Notes

 

 

 

300,000

 

 

 

 

300,000

 

 

 

 

299,264

 

 

 

 

300,000

 

 

 

 

300,000

 

 

 

 

298,926

 

March 2030 Notes (2)

 

 

 

350,000

 

 

 

 

350,000

 

 

 

 

348,530

 

 

 

 

350,000

 

 

 

 

350,000

 

 

 

 

350,860

 

March 2031 Notes (2)

 

 

 

350,000

 

 

 

 

350,000

 

 

 

 

341,598

 

 

 

 

 

 

 

 

 

 

 

 

 

Sumitomo Credit Facility

 

 

 

855,000

 

 

 

 

195,000

 

 

 

 

195,000

 

 

 

 

855,000

 

 

 

 

251,000

 

 

 

 

251,000

 

Total Debt

 

$

 

2,127,000

 

 

$

 

1,467,000

 

 

$

 

1,454,657

 

 

$

 

2,077,000

 

 

$

 

1,473,000

 

 

$

 

1,470,796

 

 

(1)
Carrying value represents aggregate principal amount outstanding less unamortized debt issuance costs.
(2)
The carrying value of the March 2030 Notes and March 2031 Notes includes the effective portion of the fair value of the interest rate swap, as further discussed in Note 7, Derivatives, to these Consolidated Financial Statements.

The combined weighted average interest rate (excluding deferred upfront financing costs and unused fees) of the aggregate borrowings outstanding for the three months ended March 31, 2026 and year ended December 31, 2025 was 4.6% and 4.8%, respectively.

The combined weighted average borrowings outstanding for the three months ended March 31, 2026 and year ended December 31, 2025 were $1.6 billion and $1.5 billion, respectively.

The following table shows the contractual maturities of our debt obligations as of March 31, 2026:

 

 

 

Payments Due by Period

 

 

 

 

 

 

 

Less than

 

 

 

 

 

 

 

 

 

 

More than

 

 

 

 

Total

 

 

 

1 year

 

 

 

1 — 3 years

 

 

 

3 — 5 years

 

 

5 years

 

2019-1 Debt

 

$

 

272,000

 

 

$

 

 

 

$

 

 

 

$

 

 

 

$

 

272,000

 

October 2026 Notes

 

 

 

300,000

 

 

 

 

300,000

 

 

 

 

 

 

 

 

 

 

 

 

 

March 2030 Notes

 

 

 

350,000

 

 

 

 

 

 

 

 

 

 

 

 

350,000

 

 

 

 

 

March 2031 Notes

 

 

 

350,000

 

 

 

 

 

 

 

 

 

 

 

 

350,000

 

 

 

 

 

Sumitomo Credit Facility

 

 

 

195,000

 

 

 

 

 

 

 

 

 

 

 

 

195,000

 

 

 

 

 

Total Debt Obligations

 

$

 

1,467,000

 

 

$

 

300,000

 

 

$

 

 

 

$

 

895,000

 

 

$

 

272,000

 

 

 

 

 

2019‑1 Debt

On August 28, 2019, the Company, through BCC Middle Market CLO 2019‑1 LLC (the “2019‑1 Issuer”), a Cayman Islands limited liability company and a wholly-owned and consolidated subsidiary of the Company, and BCC Middle Market CLO 2019‑1 Co-Issuer, LLC (the “Co-Issuer” and, together with the 2019-1 Issuer, the “Co-Issuers”), a Delaware limited liability company, completed its $501.0 million term debt securitization (the “2019‑1 CLO Transaction”). The notes issued in connection with the 2019‑1 CLO Transaction (the “2019‑1 Notes”) are secured by a diversified portfolio of the Co-Issuers consisting primarily of middle market loans, the majority of which are senior secured loans (the “2019‑1 Portfolio”). The Co-Issuers also issued Class A‑1L Loans (the “Loans” and, together with the 2019‑1 Notes, the “2019‑1 Debt”). The Loans are also secured by the 2019‑1 Portfolio. At the 2019‑1 Portfolio closing date, the 2019‑1 Portfolio was comprised of assets transferred from the Company and its consolidated subsidiaries. All transfers were eliminated in consolidation and there were no realized gains or losses recognized in the 2019‑1 CLO Transaction.

On November 30, 2021, the Co-Issuers refinanced the 2019‑1 CLO Transaction through a private placement of $410 million of senior secured and senior deferrable notes consisting of: (i) $282.5 million of Class A‑1‑R Senior Secured Floating Rate Notes, which currently bear interest at the applicable reference rate plus 1.50% per annum; (ii) $55 million of Class A‑2‑R Senior Secured Floating Rate Notes, which bear interest at the applicable reference rate plus 2.00% per annum; (iii) $47.5 million of Class B-R Senior Deferrable Floating Rate Notes, which bear interest at the applicable reference rate plus 2.60% per annum; and (iv) $25.0 million of Class C-R Senior Deferrable Floating Rate Notes, which bear interest at the applicable reference rate plus 3.75% per annum (collectively, the “2019‑1 CLO Reset Notes”). As part of the transactions, the 2019-1 Issuer was redomiciled from Cayman to Jersey. The 2019‑1 CLO Reset Notes are scheduled to mature on October 15, 2033 and the reinvestment period ends October 15, 2025. The Company retained $32.5 million of the Class B-R Notes and $25.0 million of the Class C-R Notes. The retained notes by the Company are eliminated in consolidation. The transaction resulted in a realized loss on the extinguishment of debt of $2.3 million from the acceleration of unamortized debt issuance costs. The obligations of the 2019-1 Issuer under the 2019-1 CLO Transaction are non-recourse to the Company.

On June 15, 2023, the Company entered into a Second Supplemental Indenture (“2019-1 Supplemental Indenture”), dated as of June 15, 2023, pursuant to Section 8.1(xxxi) of the Indenture, dated as of November 30, 2021, between BCC Middle Market CLO 2019-1, LTD, as issuer, and Wells Fargo Bank, National Association, as trustee. The 2019-1 Supplemental Indenture provides for, among other things, an adoption of an alternate reference rate of Term SOFR plus 0.26%, effective July 1, 2023.

On July 2, 2025, the Co-Issuers refinanced the 2019‑1 CLO Reset Notes through a $430.3 million term debt securitization in the form of a collateralized loan obligation (the “CLO Reset Transaction”). The CLO Reset Transaction was executed through the issuance by the Co-Issuers of the following classes of notes pursuant to that certain second amended and restated indenture: (i) $232.0 million of Class A-1-RR Senior Secured Floating Rate Notes, which bear interest at the three-month SOFR plus 1.45%; (ii) $16.0 million of Class A-2-RR Senior Secured Floating Rate Notes, which bear interest at the three-month SOFR plus 1.60%; (iii) $24.0 million of Class A-3-RR Senior Secured Floating Rate Notes, which bear interest at the three-month SOFR plus 1.85%; (iv) $32.0 million of Class B-RR Secured Deferrable Floating Rate Notes, which bear interest at the three-month SOFR plus 2.35%; and (v) $24.0 million of Class C-RR Secured Deferrable Floating Rate Notes, which bear interest at the three-month SOFR plus 3.35% (collectively, the “2019-1 CLO Replacement Notes”). The 2019-1 CLO Replacement Notes will mature on July 15, 2036 and the reinvestment period ends April 15, 2027. As of March 31, 2026, the Company retained $32.0 million of the Class B-RR Notes and $24.0 million of the Class C-RR Notes. The retained notes by the Company are eliminated in consolidation. Additionally, the Company holds $102.3 million in membership interests in the 2019-1 Issuer (“Membership Interests”). 100% of the Membership Interests are retained by the Company and eliminated in consolidation. The obligations of the 2019-1 Issuer under the 2019-1 CLO Transaction are non-recourse to the Company.

The 2019‑1 CLO Replacement Notes was executed through a private placement of the following 2019‑1 Debt:

 

 

 

 

 

 

 

 

 

 

 

Interest rate at

 

 

2019-1 Debt

 

Principal Amount

 

 

Spread above Index

 

March 31, 2026

 

 

Class A-1-RR Notes

 

$

 

232,000

 

 

 

1.45

 

% + 3 Month SOFR

 

 

5.12

 

%

Class A-2-RR Notes

 

 

 

16,000

 

 

 

1.60

 

% + 3 Month SOFR

 

 

5.27

 

%

Class A-3-RR Notes

 

 

 

24,000

 

 

 

1.85

 

% + 3 Month SOFR

 

 

5.52

 

%

Total 2019-1 Debt

 

$

 

272,000

 

 

 

 

 

 

 

 

 

The Company serves as portfolio manager of the 2019‑1 Issuer pursuant to a portfolio management agreement between the Company and the 2019-1 Issuer. For so long as the Company serves as portfolio manager, the Company will not charge any management fee or subordinated interest to which it may be entitled.

During the reinvestment period, pursuant to the indenture and loan agreement governing the 2019‑1 Notes and Loans, respectively, all principal collections received on the underlying collateral may be used by the 2019‑1 Issuer to purchase new collateral under the direction of the Company in its capacity as portfolio manager of the 2019‑1 Issuer and in accordance with the 2019‑1 Issuer investment strategy and the terms of the indenture and loan agreement, as applicable.

The Company has agreed to hold on an ongoing basis the membership interests with an aggregate dollar purchase price at least equal to 5% of the aggregate amount of all obligations issued by the 2019‑1 Co-Issuers for so long as the 2019‑1 Debt remains outstanding.

The 2019‑1 Issuer pays ongoing administrative expenses to the trustee, independent accountants, legal counsel, rating agencies and independent managers in connection with developing and maintaining reports, and providing required services in connection with the administration of the 2019‑1 Issuer.

As of March 31, 2026, there were 52 first lien senior secured loans with a total fair value of approximately $395.7 million and cash of $11.7 million securing the 2019-1 Debt. As of December 31, 2025, there were 48 first lien senior secured loans with a total fair value of approximately $380.6 million and cash of $26.8 million securing the 2019-1 Debt. Assets that are pledged as collateral for the 2019-1 Debt are not directly available to the creditors of the Company to satisfy any obligations of the Company other than the Company’s obligations under the indenture and loan agreement governing the 2019-1 Debt. The creditors of the 2019-1 Co-Issuers have received security interests in such assets and such assets are not intended to be available to the creditors of the Company (or an affiliate of the Company). The 2019-1 Portfolio must meet certain requirements, including asset mix and concentration, term, agency rating, collateral coverage, minimum coupon, minimum spread and sector diversity requirements in the indenture and loan agreement governing the 2019-1 Debt. As of March 31, 2026, the Company was in compliance with its covenants related to the 2019-1 Debt.

Costs incurred in connection with the offering of the 2019‑1 CLO Reset Notes and the 2019‑1 CLO Replacement Notes have been recorded as debt issuance costs and presented as a reduction to the outstanding principal amount of the 2019‑1 Debt on the Consolidated Statements of Assets and Liabilities and are being amortized over the life using the effective interest method. The balance of the unamortized debt issuance costs was $1.7 million and $1.8 million as of March 31, 2026 and December 31, 2025, respectively.

For the three months ended March 31, 2026 and 2025, the components of interest expense related to the 2019‑1 Co-Issuers were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Borrowing interest expense

 

$

 

3,556

 

 

$

 

5,509

 

Unused facility fee

 

 

 

 

 

 

 

 

Amortization of deferred financing costs and upfront commitment fees

 

 

 

41

 

 

 

 

32

 

Total interest and debt financing expenses

 

$

 

3,597

 

 

$

 

5,541

 

 

March 2026 Notes

On March 10, 2021, the Company and U.S. Bank National Association (the “Trustee”), entered into an Indenture (the “Base Indenture”) and First Supplemental Indenture (the “First Supplemental Indenture,” and together with the Base Indenture, the “Indenture”) between the Company and the Trustee. The First Supplemental Indenture relates to the Company’s issuance of $300.0 million aggregate principal amount of its 2.95% notes due 2026 (the “March 2026 Notes”).

The March 2026 Notes matured on March 10, 2026. The March 2026 Notes bore interest at a rate of 2.95% per year payable semi-annually on March 10th and September 10th of each year, commencing on September 10, 2021. The March 2026 Notes were general unsecured obligations of the Company that ranked senior in right of payment to all of the Company’s then existing and future indebtedness that was expressly subordinated in right of payment to the March 2026 Notes, ranked pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, ranked effectively junior to any of the Company’s secured indebtedness (including unsecured indebtedness that the Company later secured) to the extent of the value of the assets securing such indebtedness, and ranked structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries, financing vehicles or similar facilities.

The net proceeds to the Company in connection with the issuance of the March 2026 Notes were approximately $294.3 million, after deducting the underwriting discounts and commissions of $4.4 million and offering expenses of $1.3 million.

As of March 31, 2026 and December 31, 2025, the components of the carrying value of the March 2026 Notes were as follows:

 

 

 

 

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Principal amount of debt

 

$

 

 

 

$

 

300,000

 

Unamortized debt issuance cost

 

 

 

 

 

 

 

(122

)

Original issue discount, net of accretion

 

 

 

 

 

 

 

(92

)

Carrying value of March 2026 Notes

 

$

 

 

 

$

 

299,786

 

 

For the three months ended March 31, 2026 and 2025, the components of interest expense related to the March 2026 Notes were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Borrowing interest expense

 

$

 

1,696

 

 

$

 

2,213

 

Amortization of debt issuance cost

 

 

 

122

 

 

 

 

160

 

Accretion of original issue discount

 

 

 

92

 

 

 

 

118

 

Total interest and debt financing expenses

 

$

 

1,910

 

 

$

 

2,491

 

 

October 2026 Notes

On October 13, 2021, the Company and the Trustee entered into a Second Supplemental Indenture (the “Second Supplemental Indenture”) to the Indenture between the Company and the Trustee. The Second Supplemental Indenture relates to the Company’s issuance of $300.0 million aggregate principal amount of its 2.55% notes due 2026 (the “October 2026 Notes”).

The October 2026 Notes will mature on October 13, 2026 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the Indenture. The October 2026 Notes bear interest at a rate of 2.55% per year payable semi-annually on April 13 and October 13 of each year, commencing on April 13, 2022. The October 2026 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company’s existing and future indebtedness that is expressly subordinated in right of payment to the October 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries, financing vehicles or similar facilities.

The net proceeds to the Company were approximately $293.1 million, after deducting the underwriting discounts and commissions of $6.2 million and offering expenses of $0.7 million.

As of March 31, 2026 and December 31, 2025, the components of the carrying value of the October 2026 Notes were as follows:

 

 

 

 

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Principal amount of debt

 

$

 

300,000

 

 

$

 

300,000

 

Unamortized debt issuance cost

 

 

 

(392

)

 

 

 

(572

)

Original issue discount, net of accretion

 

 

 

(344

)

 

 

 

(502

)

Carrying value of October 2026 Notes

 

$

 

299,264

 

 

$

 

298,926

 

 

 

For the three months ended March 31, 2026 and 2025, the components of interest expense related to the October 2026 Notes were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Borrowing interest expense

 

$

 

1,913

 

 

$

 

1,913

 

Amortization of debt issuance cost

 

 

 

180

 

 

 

 

181

 

Accretion of original issue discount

 

 

 

158

 

 

 

 

157

 

Total interest and debt financing expenses

 

$

 

2,251

 

 

$

 

2,251

 

 

Sumitomo Credit Facility

On December 24, 2021, the Company entered into a senior secured revolving credit agreement (as amended to date, the “Sumitomo Credit Agreement” or the “Sumitomo Credit Facility”) as Borrower, with Sumitomo Mitsui Banking Corporation, as Administrative Agent and Sole Book Runner, and with Sumitomo Mitsui Banking Corporation and MUFG Union Bank, N.A., as Joint Lead Arrangers. The Credit Agreement is effective as of December 24, 2021.

The facility amount under the Sumitomo Credit Agreement is $300.0 million with an accordion provision to permit increases to the total facility amount up to $1.0 billion. Proceeds of the loans under the Sumitomo Credit Agreement may be used for general corporate purposes of the Company, including, without limitation, repaying outstanding indebtedness, making distributions, contributions and investments, and acquisition and funding, and such other uses as permitted under the Sumitomo Credit Agreement. The original maturity date was December 24, 2026.

On July 6, 2022, the Company entered into the First Amendment to the Sumitomo Credit Agreement. The First Amendment provides for an upsize in the total commitments from lenders under the revolving credit facility governed by the Sumitomo Credit Agreement from $300.0 million to $385.0 million. The First Amendment also replaced the LIBOR benchmark provisions under the Sumitomo Credit Agreement with SOFR benchmark provisions, including applicable credit spread adjustments.

On July 22, 2022, the Company entered into the Increasing Lender/Joinder Lender Agreement (the “Joinder Agreement”), dated as of July 22, 2022, pursuant to Section 2.08(e) of the Sumitomo Credit Agreement. The Joinder Agreement provides for, among other things, an upsize in the total commitments from lenders under the revolving credit facility governed by the Sumitomo Credit Agreement from $385.0 million to $485.0 million.

On August 24, 2022, the Company entered into the Second Amendment, which provides for, among other things, an upsize in the total commitments from lenders under the Sumitomo Credit Agreement from $485.0 million to $635.0 million.

On December 14, 2022, the Company entered into a second Increasing Lender/Joinder Lender Agreement (the “Second Joinder Agreement”), dated as of December 14, 2022, pursuant to Section 2.08(e) of the Sumitomo Credit Agreement. The Second Joinder Agreement provides for, among other things, an upsize in the total commitments from lenders under the revolving credit facility governed by the Sumitomo Credit Agreement from $635.0 million to $665.0 million.

On May 20, 2024, the Company entered into the Third Amendment to the Sumitomo Credit Agreement (the “Third Amendment”). The Third Amendment provides for, among other things, (i) an extension of the revolver availability period from December 24, 2025 to May 19, 2028, (ii) an extension of the scheduled maturity date from December 24, 2026 to May 18, 2029, (iii) the conversion of a portion of the existing revolver availability into term loan availability, (iv) an upsize in the total facility amount from $665,000,000 to $855,000,000, (v) an increase in the accordion provision to permit increases to a total facility amount of up to $1,500,000,000, (vi) the reduction of the credit adjustment spread for term benchmark loans denominated in Dollars, from 0.10% for one-month tenor loans, 0.15% for three-month tenor loans and 0.25% for six-month tenor loans to 0.10% for all loan tenors, and (vii) the joinder of new lenders to the Sumitomo Credit Agreement.

Interest under the Sumitomo Credit Agreement for (i) loans for which the Company elects the base rate option, (A) if the borrowing base is equal to or greater than the product of 1.60 and the revolving credit exposure, is payable at an “alternate base rate” (which is the greater of zero and the highest of (a) the prime rate as published in the print edition of The Wall Street Journal, Money Rates Section, (b) the federal funds effective rate plus 0.5% and (c) the one-month Eurocurrency rate plus 1% per annum) plus 0.75% per annum and (B) if the borrowing base is less than the product of 1.60 and the revolving credit exposure, the alternate base rate plus 0.875% per annum; (ii) loans for which the Company elects the Eurocurrency option, (A) if the borrowing base is equal to or greater

than the product of 1.60 and the revolving credit exposure, is payable at a rate equal to the Eurocurrency rate plus 1.75% per annum and (B) if the borrowing base is less than the product of 1.60 and the revolving credit exposure, is payable at a rate equal to the Eurocurrency rate plus 1.875% per annum; and (iii) loans for which the Company elects the risk-free-rate option, (A) if the borrowing base is equal to or greater than the product of 1.60 and the revolving credit exposure, is payable at a rate equal to risk-free-rate plus 1.8693% per annum and (B) if the borrowing base is less than the product of 1.60 and the revolving credit exposure, is payable at a rate equal to risk-free-rate plus 1.9943% per annum. The Company pays a commitment fee of 37.5 basis points (0.375%) on the average daily unused amount of the dollar commitment.

The Sumitomo Credit Agreement includes customary affirmative and negative covenants, including certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for revolving credit facilities of this nature. As of March 31, 2026, the Company was in compliance with its covenants related to the Sumitomo Credit Facility.

As of March 31, 2026 and December 31, 2025, there were $195.0 million and $251.0 million of borrowings under the Sumitomo Credit Facility.

For the three months ended March 31, 2026 and 2025, the components of interest expense related to the Sumitomo Credit Facility were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Borrowing interest expense

 

$

 

2,484

 

 

$

 

4,456

 

Unused facility fee

 

 

 

642

 

 

 

 

544

 

Accretion of original issue discount

 

 

 

259

 

 

 

 

258

 

Total interest and debt financing expenses

 

$

 

3,385

 

 

$

 

5,258

 

 

 

 

March 2030 Notes

On February 6, 2025, the Company and the Trustee entered into a Third Supplemental Indenture (the “Third Supplemental Indenture”) to the Indenture between the Company and the Trustee. The Third Supplemental Indenture relates to the Company’s issuance of $350.0 million aggregate principal amount of its 5.95% notes due 2030 (the “March 2030 Notes”).

The March 2030 Notes will mature on March 15, 2030 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the Indenture. The March 2030 Notes bear interest at a rate of 5.95% per year payable semi-annually on March 15 and September 15 of each year, commencing on September 15, 2025. The March 2030 Notes are general unsecured obligations of the Company that rank senior in right of payment to all the Company's existing and future indebtedness that is expressly subordinated in right of payment to the March 2030 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries, financing vehicles or similar facilities.

The net proceeds to the Company were approximately $341.4 million, after deducting the underwriting discounts and commissions of $7.5 million and offering expenses of $1.1 million.

In connection with the March 2030 Notes, the Company entered into an interest rate swap to more closely align the interest rates of the Company’s liabilities with the Company’s investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement related to the March 2030 Notes, the Company receives a fixed interest rate of 5.95% per annum receivable semiannually on March 15 and September 15 of each year, and pays a floating interest rate of SOFR + 1.90% per annum payable quarterly on March 15, June 15, September 15, and December 15 of each year, on $350 million of the March 2030 Notes. The Company designated each interest rate swap as the hedging instrument in a qualifying hedge accounting relationship. Please see “Item 1. Consolidated Financial Statements - Notes to Consolidated Financial Statements - Note 7. Derivatives” for additional detail.

As of March 31, 2026 and December 31, 2025, the components of the carrying value of the March 2030 Notes were as follows:

 

 

 

 

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Principal amount of debt

 

$

 

350,000

 

 

$

 

350,000

 

Unamortized debt issuance cost

 

 

 

(3,552

)

 

 

 

(3,773

)

Original issue discount, net of accretion

 

 

 

(3,081

)

 

 

 

(3,273

)

Effective interest rate swap hedge

 

 

 

5,163

 

 

 

 

7,906

 

Carrying value of March 2030 Notes

 

$

 

348,530

 

 

$

 

350,860

 

For the three months ended March 31, 2026 and 2025, the components of interest expense related to the March 2030 Notes were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Borrowing interest expense

 

$

 

5,206

 

 

$

 

3,124

 

Amortization of debt issuance cost

 

 

 

221

 

 

 

 

130

 

Accretion of original issue discount

 

 

 

192

 

 

 

 

113

 

Interest rate swaps

 

 

 

(264

)

 

 

 

74

 

Hedged items

 

 

 

(45

)

 

 

 

(78

)

Total interest and debt financing expenses

 

$

 

5,310

 

 

$

 

3,363

 

 

March 2031 Notes

On January 29, 2026, the Company and the Trustee entered into a Fourth Supplemental Indenture (the “Fourth Supplemental Indenture”) to the Base Indenture (the Base Indenture together with the Fourth Supplemental Indenture, the “New Indenture”). The Fourth Supplemental Indenture relates to the Company’s issuance of $350.0 million aggregate principal amount of its 5.95% notes due 2031 (the “March 2031 Notes”).

The March 2031 Notes will mature on March 1, 2031 and may be redeemed in whole or in part at the Company’s option at any time or from time to time at the redemption prices set forth in the New Indenture. The March 2031 Notes bear interest at a rate of 5.95% per year payable semi-annually on March 1 and September 1 of each year, commencing on September 1, 2026. The March 2031 Notes are general unsecured obligations of the Company that rank senior in right of payment to all of the Company’s existing and future indebtedness that is expressly subordinated in right of payment to the March 2031 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by the Company, rank effectively junior to any of the Company’s secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries, financing vehicles or similar facilities.

The net proceeds to the Company were approximately $341.7 million, after deducting the underwriting discounts and commissions of $7.2 million and offering expenses of $1.1 million.

In connection with the March 2031 Notes, the Company entered into an interest rate swap to more closely align the interest rates of the Company’s liabilities with the Company’s investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement related to the March 2031 Notes, the Company receives a fixed interest rate of 5.95% per annum receivable semiannually on March 1 and September 1 of each year, and pays a floating interest rate of SOFR + 2.28% per annum payable quarterly on March 1, June 1, September 1, and December 1 of each year, on $350 million of the March 2031 Notes. The Company designated each interest rate swap as the hedging instrument in a qualifying hedge accounting relationship. Please see “Item 1. Consolidated Financial Statements - Notes to Consolidated Financial Statements - Note 7. Derivatives” for additional detail.

 

As of March 31, 2026 and December 31, 2025, the components of the carrying value of the March 2031 Notes were as follows:

 

 

 

 

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Principal amount of debt

 

$

 

350,000

 

 

$

 

 

Unamortized debt issuance cost

 

 

 

(4,435

)

 

 

 

 

Original issue discount, net of accretion

 

 

 

(3,605

)

 

 

 

 

Effective interest rate swap hedge

 

 

 

(362

)

 

 

 

 

Carrying value of March 2031 Notes

 

$

 

341,598

 

 

$

 

 

 

For the three months ended March 31, 2026 and 2025, the components of interest expense related to the March 2031 Notes were as follows:

 

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Borrowing interest expense

 

$

 

3,587

 

 

$

 

 

Amortization of debt issuance cost

 

 

 

151

 

 

 

 

 

Accretion of original issue discount

 

 

 

122

 

 

 

 

 

Interest rate swaps

 

 

 

2

 

 

 

 

 

Hedged items

 

 

 

(63

)

 

 

 

 

Total interest and debt financing expenses

 

$

 

3,799

 

 

$